Your browser doesn't support javascript.
loading
Verification of a clinical decision support system for the diagnosis of headache disorders based on patient-computer interactions: a multi-center study.
Han, Xun; Wan, Dongjun; Zhang, Shuhua; Yin, Ziming; Huang, Siyang; Xie, Fengbo; Guo, Junhong; Qu, Hongli; Yao, Yuanrong; Xu, Huifang; Li, Dongfang; Chen, Sufen; Wang, Faming; Wang, Hebo; Chen, Chunfu; He, Qiu; Dong, Ming; Wan, Qi; Xu, Yanmei; Chen, Min; Yan, Fanhong; Wang, Xiaolin; Wang, Rongfei; Zhang, Mingjie; Ran, Ye; Jia, Zhihua; Liu, Yinglu; Chen, Xiaoyan; Hou, Lei; Zhao, Dengfa; Dong, Zhao; Yu, Shengyuan.
Afiliação
  • Han X; Department of Neurology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
  • Wan D; International Headache Centre, Chinese PLA General Hospital, Beijing, 100853, China.
  • Zhang S; Department of Neurology, The 940Th Hospital of Joint Logistic Support Force of Chinese People's Liberation Army, Lanzhou, 730050, Gansu, China.
  • Yin Z; Department of Neurology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
  • Huang S; International Headache Centre, Chinese PLA General Hospital, Beijing, 100853, China.
  • Xie F; School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China.
  • Guo J; AffaMed Therapeutics, Suite 4501, Tower A, Guomao, No. 1 Jianguomenwai Avenue, Beijing, 100004, Chaoyang District, China.
  • Qu H; AffaMed Therapeutics, Suite 4501, Tower A, Guomao, No. 1 Jianguomenwai Avenue, Beijing, 100004, Chaoyang District, China.
  • Yao Y; Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
  • Xu H; Department of Neurology, The First Affiliated Hospital of Xiamen University, Xiamen, 361003, Fujian, China.
  • Li D; Department of Neurology, Guizhou Province People's Hospital, Guiyang, 550002, Guizhou, China.
  • Chen S; Department of Neurology, Wuhan NO.1 Hospital, Wuhan, 430022, Hubei, China.
  • Wang F; Department of Neurology, Second Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
  • Wang H; Department of Neurology, Changsha Central Hospital Affiliated to University of South China, Changsha, 410004, Hunan, China.
  • Chen C; Department of Neurology, Tiantai People's Hospital of Zhejiang Province, Taizhou, 317200, Zhejiang, China.
  • He Q; Department of Neurology, Hebei General Hospital, Shijiazhuang, 050051, Hebei, China.
  • Dong M; Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.
  • Wan Q; Department of Neurology, The People's Hospital of Liaoning Province, Shenyang, 110067, Liaoning, China.
  • Xu Y; Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Jilin, 130031, China.
  • Chen M; Department of Neurology, Jiangsu Province Hospital, Nanjing, 210029, Jiangsu, China.
  • Yan F; Department of Neurology, Dingyuan General Hospital, Chuzhou, 233290, Anhui, China.
  • Wang X; Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Wang R; Department of Neurology, Linyi Jinluo Hospital, Linyi, 276000, Shandong, China.
  • Zhang M; Department of Neurology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
  • Ran Y; International Headache Centre, Chinese PLA General Hospital, Beijing, 100853, China.
  • Jia Z; Department of Neurology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
  • Liu Y; International Headache Centre, Chinese PLA General Hospital, Beijing, 100853, China.
  • Chen X; Department of Neurology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
  • Hou L; International Headache Centre, Chinese PLA General Hospital, Beijing, 100853, China.
  • Zhao D; Department of Neurology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
  • Dong Z; International Headache Centre, Chinese PLA General Hospital, Beijing, 100853, China.
  • Yu S; Department of Neurology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
J Headache Pain ; 24(1): 57, 2023 May 23.
Article em En | MEDLINE | ID: mdl-37217887
BACKGROUND: Although headache disorders are common, the current diagnostic approach is unsatisfactory. Previously, we designed a guideline-based clinical decision support system (CDSS 1.0) for diagnosing headache disorders. However, the system requires doctors to enter electronic information, which may limit widespread use. METHODS: In this study, we developed the updated CDSS 2.0, which handles clinical information acquisition via human-computer conversations conducted on personal mobile devices in an outpatient setting. We tested CDSS 2.0 at headache clinics in 16 hospitals in 14 provinces of China. RESULTS: Of the 653 patients recruited, 18.68% (122/652) were suspected by specialists to have secondary headaches. According to "red-flag" responses, all these participants were warned of potential secondary risks by CDSS 2.0. For the remaining 531 patients, we compared the diagnostic accuracy of assessments made using only electronic data firstly. In Comparison A, the system correctly recognized 115/129 (89.15%) cases of migraine without aura (MO), 32/32 (100%) cases of migraine with aura (MA), 10/10 (100%) cases of chronic migraine (CM), 77/95 (81.05%) cases of probable migraine (PM), 11/11 (100%) cases of infrequent episodic tension-type headache (iETTH), 36/45 (80.00%) cases of frequent episodic tension-type headache (fETTH), 23/25 (92.00%) cases of chronic tension-type headache (CTTH), 53/60 (88.33%) cases of probable tension-type headache (PTTH), 8/9 (88.89%) cases of cluster headache (CH), 5/5 (100%) cases of new daily persistent headache (NDPH), and 28/29 (96.55%) cases of medication overuse headache (MOH). In Comparison B, after combining outpatient medical records, the correct recognition rates of MO (76.03%), MA (96.15%), CM (90%), PM (75.29%), iETTH (88.89%), fETTH (72.73%), CTTH (95.65%), PTTH (79.66%), CH (77.78%), NDPH (80%), and MOH (84.85%) were still satisfactory. A patient satisfaction survey indicated that the conversational questionnaire was very well accepted, with high levels of satisfaction reported by 852 patients. CONCLUSIONS: The CDSS 2.0 achieved high diagnostic accuracy for most primary and some secondary headaches. Human-computer conversation data were well integrated into the diagnostic process, and the system was well accepted by patients. The follow-up process and doctor-client interactions will be future areas of research for the development of CDSS for headaches.
Assuntos
Palavras-chave

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Cefaleia Histamínica / Cefaleia do Tipo Tensional / Sistemas de Apoio a Decisões Clínicas / Enxaqueca com Aura / Transtornos da Cefaleia / Transtornos da Cefaleia Secundários / Transtornos de Enxaqueca Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Cefaleia Histamínica / Cefaleia do Tipo Tensional / Sistemas de Apoio a Decisões Clínicas / Enxaqueca com Aura / Transtornos da Cefaleia / Transtornos da Cefaleia Secundários / Transtornos de Enxaqueca Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article